Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2026-02-23 @ 1:11 AM
Study NCT ID:
NCT01747135
Status:
COMPLETED
Last Update Posted:
2021-07-23
First Post:
2012-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Sponsor:
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company
Organization: